Société Goodbody Health Canadian Securities Exchange
Actions
SWEL
CA3821591011
Produits pharmaceutiques
Métier
Ventes par activité
USD en Millions | 2020 | Poids | 2021 | Poids | Delta |
---|---|---|---|---|---|
Clinic Testing
92,6
%
| 1 | 20,5 % | 22 | 92,6 % | +4 049,80 % |
Cannaboid Products
3,8
%
| 2 | 64,5 % | 1 | 3,8 % | -45,40 % |
Wholesale
2,4
%
| 0 | 2,2 % | 1 | 2,4 % | +883,77 % |
Cannaboid Testing
1,2
%
| 0 | 12,8 % | 0 | 1,2 % | -16,19 % |
Ventes par région
USD en Millions | 2020 | Poids | 2021 | Poids | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 3 | 100,0 % | 23 | 100,0 % | +817,37 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Emily Critchley
HRO | Human Resources Officer | - | - |
Paul van Issum
PRN | Corporate Officer/Principal | - | - |
Anne Tew
SEC | Corporate Secretary | - | 01/11/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Anne Tew
SEC | Corporate Secretary | - | 01/11/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 364 962 760 | 256 430 105 ( 70,26 %) | 0 | 70,26 % |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Sativa Group Plc
Sativa Group Plc Financial ConglomeratesFinance Sativa Group Plc engages in the production, testing and compliance, commercialization, sales, and marketing of cannabidiol products. It operates through the following segments: Products; Testing; and Extraction and Research and Development. The Products segment focuses in the sale of cannabidiol products. The Testing segment involves in testing cannabidiol products. The Extraction and Research and Development segment include extraction and research and development operations which develops future products. The company was founded by Geremy Howard Prance Thomas on December 19, 2017 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Secteur
Ventes par activité
Varia. 1 janv. | Capi. | |
---|---|---|
+37,08 % | 6,01 Md | |
-17,43 % | 4,4 Md | |
-9,46 % | 3,17 Md | |
+0,51 % | 3,07 Md | |
-3,53 % | 2,51 Md | |
+41,15 % | 1,88 Md | |
-5,15 % | 1,73 Md | |
+0,09 % | 1,65 Md | |
-10,38 % | 1,58 Md |